<DOC>
	<DOCNO>NCT00829244</DOCNO>
	<brief_summary>The overall objective trial compare ovarian response assist reproductive technology ( ART ) subject administered GONAL f® accord 'Consistency recombinant follicle stimulate hormone [ r-FSH ] start dos individualize treatment ' ( CONSORT ) calculator versus give standard GONAL f® dose 150 International Unit ( IU ) per day .</brief_summary>
	<brief_title>CONSORT Randomized Controlled Trial Assisted Reproductive Technology</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>1 . Female subject justify invitro fertilization ( IVF ) /embryo transfer ( ET ) treatment 2 . Have male partner semen analysis within past 6 month prior randomization consider adequate proceed regular insemination intracytoplasmic sperm injection ( ICSI ) accord center 's standard practice . If criterion meet , subject enter donor sperm use 3 . Between 18th 35th birthday ( 35 include ) time randomization visit 4 . Body mass index ( BMI ) low 30 kilogram per square meter ( kg/m^2 ) BMI calculate accord formula 5 . Have regular spontaneous ovulatory menstrual cycle 21 35 day length 6 . Have early follicular phase ( Day 24 ) serum level basal FSH low equal 12 International Unit per Liter ( IU/L ) measure center 's local laboratory screen period ( i.e . within 2 month prior downregulation start ) 7 . Presence ovaries 8 . Normal uterine cavity , investigator 's opinion compatible pregnancy 9 . Have negative cervical papanicolaou ( PAP ) test within last 6 month prior randomization 10 . Have least 1 washout cycle ( define great equal 30 day since last dose clomiphene citrate gonadotrophin treatment ) since last ART cycle and/or clomiphene citrate gonadotrophin treatment prior start gonadotropin release hormone ( GnRH ) agonist therapy 11 . Willing able comply protocol duration trial 12 . Have give write informed consent , prior trialrelated procedure part normal medical care , understand consent may withdraw subject time without prejudice future medical care 1 . Have great equal 2 previous ART cycle poor response gonadotrophin stimulation ( define low equal 5 mature follicle and/or low equal 3 oocyte collect ) great equal 2 previous ART cycle hyper response ( define great equal 25 oocyte retrieve ) 2 . Any medical condition , judgment investigator may interfere absorption , distribution , metabolism excretion drug . In case doubt , subject question discuss Merck Serono 's Medical responsible 3 . Have previous severe ovarian hyperstimulation syndrome ( OHSS ) 4 . Polycystic ovary syndrome ( PCOS ; Rotterdam criterion ) reduce risk occurrence OHSS 5 . Presence endometriosis require treatment 6 . Uterine myoma require treatment 7 . Any contraindication pregnant and/or carry pregnancy term 8 . Extrauterine pregnancy within last 3 month prior screen 9 . History 3 miscarriage ( early late miscarriage ) due cause 10 . Tumors hypothalamus pituitary gland 11 . Ovarian enlargement cyst unknown etiology 12 . Ovarian , uterine mammary cancer 13 . A clinically significant systemic disease 14 . Known infection Human Immunodeficiency Virus ( HIV ) , Hepatitis B C virus trial subject male partner , 15 . Abnormal gynecological bleeding undetermined origin 16 . Known allergy hypersensitivity human gonadotrophin preparation , 17 . Any active substance abuse history drug medication alcohol abuse past 5 year prior screen visit 18 . Entered previously trial simultaneous participation another clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>34 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Infertility</keyword>
	<keyword>Assisted reproductive technology</keyword>
</DOC>